Cochrane · systematic review · CD009860

Surgery for trigger finger

Fiorini, HJ, Tamaoki, MJ, Lenza, M, et al. · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library

MusculoskeletalAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
63
current version
GRADE rated
27
No studies
36
Included studies
NR
No studies 36 · 57.1%Ungraded 0 · 0%Very low 21 · 33.3%Low 6 · 9.5%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Open surgery versus steroid injection for treating trigger finger

Population: patients with trigger finger
7 questions
OutcomeEffectEvidenceStatus / GRADE
Resolution of symptoms (after one or more injections)
Open surgery vs steroid injection
RR 1.48 [0.79, 2.76]2 studies · 270 participantsVery low
Downgraded: risk of bias
Pain Proportion with pain on the palm of the hand
Open surgery vs steroid injection
RR 3.69 [1.99, 6.85]1 study · 105 participantsLow
Downgraded: risk of bias
Function Not measured
Open surgery vs steroid injection
no estimate extractedNRNo studies
Participant global assessment of success Not measured
Open surgery vs steroid injection
no estimate extractedNRNo studies
Recurrence
Open surgery vs steroid injection
RR 0.17 [0.09, 0.33]2 studies · 270 participantsLow
Downgraded: risk of bias
Adverse events (infection, tendon or pulley injury, flare, cutaneous discomfort, fat necrosis)
Open surgery vs steroid injection
RR 1.02 [0.57, 1.84]2 studies · 270 participantsLow
Downgraded: risk of bias
Neurovascular injury
Open surgery vs steroid injection
RR 2.17 [0.7, 6.77]2 studies · 270 participantsLow
Downgraded: risk of bias

Percutaneous surgery versus steroid injection for treating trigger finger

Population: patients with trigger finger
7 questions
OutcomeEffectEvidenceStatus / GRADE
Resolution of symptoms (after 1 or more injections)
Percutaneous surgery vs steroid injection
RR 2.11 [0.31, 14.51]2 studies · 191 participantsVery low
Downgraded: risk of bias
Pain (Visual analogue scale: 0 to 10 points)
Percutaneous surgery vs steroid injection
no estimate extracted2 studies · 222 participantsVery low
Downgraded: risk of bias
Function Not measured
Percutaneous surgery vs steroid injection
no estimate extractedNRNo studies
Participant global assessment of success Not measured
Percutaneous surgery vs steroid injection
no estimate extractedNRNo studies
Recurrence
Percutaneous surgery vs steroid injection
RR 0.57 [0.21, 1.59]5 studies · 392 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Adverse events (infection, partial loss of movement, tendon or −0 injury, dysaesthesia, and skin atrophy or hypopigmentation)
Percutaneous surgery vs steroid injection
RR 1.58 [0.91, 2.75]5 studies · 392 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Neurovascular injury
Percutaneous surgery vs steroid injection
RR 0.35 [0.04, 3.29]2 studies · 191 participantsLow
Downgraded: risk of bias

Open surgery versus steroid injection plus hyaluronic acid injection guided by ultrasound for treating trigger finger

Population: patients with trigger finger
7 questions
OutcomeEffectEvidenceStatus / GRADE
Resolution of symptoms
Open surgery vs steroid injection plus hyaluronic acid injection guided by ultrasound
RR 1.35 [0.98, 1.85]1 study · 30 participantsVery low
Downgraded: risk of bias
Pain (short‐term) Not measured
Open surgery vs steroid injection plus hyaluronic acid injection guided by ultrasound
no estimate extractedNRNo studies
Function Not measured
Open surgery vs steroid injection plus hyaluronic acid injection guided by ultrasound
no estimate extractedNRNo studies
Participant global assessment of success Not measured
Open surgery vs steroid injection plus hyaluronic acid injection guided by ultrasound
no estimate extractedNRNo studies
Recurrence
Open surgery vs steroid injection plus hyaluronic acid injection guided by ultrasound
RR 0.14 [0.01, 2.55]1 study · 30 participantsVery low
Downgraded: risk of bias
Adverse events (partial loss of movement, algodystrophic syndrome)
Open surgery vs steroid injection plus hyaluronic acid injection guided by ultrasound
RR 3 [0.35, 25.68]1 study · 30 participantsVery low
Downgraded: risk of bias
Neurovascular injury Not measured
Open surgery vs steroid injection plus hyaluronic acid injection guided by ultrasound
no estimate extractedNRNo studies

Percutaneous surgery plus steroid injection compared to steroid injection for trigger finger

Population: patients with trigger finger
7 questions
OutcomeEffectEvidenceStatus / GRADE
Resolution of symptoms (after 1 or more injections)
Percutaneous surgery plus steroid injection vs steroid injection
RR 1.51 [1.21, 1.9]1 study · 127 participantsVery low
Downgraded: risk of bias
Pain (short‐term) Not measured
Percutaneous surgery plus steroid injection vs steroid injection
no estimate extractedNRNo studies
Function Not measured
Percutaneous surgery plus steroid injection vs steroid injection
no estimate extractedNRNo studies
Participant global assessment of success Not measured
Percutaneous surgery plus steroid injection vs steroid injection
no estimate extractedNRNo studies
Recurrence Not measured
Percutaneous surgery plus steroid injection vs steroid injection
no estimate extractedNRNo studies
Adverse events (infection, partial loss of movement)
Percutaneous surgery plus steroid injection vs steroid injection
RR 0.92 [0.13, 6.36]1 study · 127 participantsVery low
Downgraded: risk of bias
Neurovascular injury
Percutaneous surgery plus steroid injection vs steroid injection
RR 0.92 [0.06, 14.46]1 study · 127 participantsVery low
Downgraded: risk of bias

Percutaneous surgery versus open surgery for treating trigger finger

Population: patients with trigger finger
7 questions
OutcomeEffectEvidenceStatus / GRADE
Resolution of symptoms
Percutaneous surgery vs open surgery
RR 1 [0.97, 1.02]5 studies · 429 participantsLow
Downgraded: risk of bias
Pain (1 to 6 scale)
Percutaneous surgery vs open surgery
no estimate extracted1 study · 36 participantsVery low
Downgraded: risk of bias, imprecision
Function Not measured
Percutaneous surgery vs open surgery
no estimate extractedNRNo studies
Participant global assessment of success Not measured
Percutaneous surgery vs open surgery
no estimate extractedNRNo studies
Recurrence
Percutaneous surgery vs open surgery
RR 0.28 [0.01, 6.83]4 studies · 397 participantsVery low
Downgraded: risk of bias, imprecision
Adverse events (infection, partial loss of movement, tendon or pulley injury, oedema or inflammation or hematoma, adherence)
Percutaneous surgery vs open surgery
RR 0.8 [0.17, 3.68]5 studies · 429 participantsVery low
Downgraded: risk of bias
Neurovascular injury
Percutaneous surgery vs open surgery
no estimate extracted4 studies · 397 participantsVery low
Downgraded: risk of bias, imprecision

Endoscopic surgery versus open surgery for treating trigger finger

Population: patients with trigger finger
7 questions
OutcomeEffectEvidenceStatus / GRADE
Resolution of symptoms
Endoscopic surgery vs open surgery
RR 1 [0.98, 1.02]1 study · 231 participantsVery low
Downgraded: risk of bias
Pain (short‐term) Not measured
Endoscopic surgery vs open surgery
no estimate extractedNRNo studies
Function Not measured
Endoscopic surgery vs open surgery
no estimate extractedNRNo studies
Participant global assessment of success Not measured
Endoscopic surgery vs open surgery
no estimate extractedNRNo studies
Recurrence Not measured
Endoscopic surgery vs open surgery
no estimate extractedNRNo studies
Adverse events (infection, dysaesthesia)
Endoscopic surgery vs open surgery
RR 2.74 [0.74, 10.06]1 study · 231 participantsVery low
Downgraded: risk of bias
Neurovascular injury
Endoscopic surgery vs open surgery
RR 3.08 [0.13, 74.79]1 study · 231 participantsVery low
Downgraded: risk of bias

Open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease compared to open surgery by longitudinal incision of the skin for trigger finger

Population: patients with trigger finger
7 questions
OutcomeEffectEvidenceStatus / GRADE
Resolution of symptoms Not measured
Open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease vs open surgery by longitudinal incision of the skin
no estimate extractedNRNo studies
Pain (short‐term) Not measured
Open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease vs open surgery by longitudinal incision of the skin
no estimate extractedNRNo studies
Function (DASH score: 0 to 100 points)
Open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease vs open surgery by longitudinal incision of the skin
no estimate extracted1 study · 21 participantsVery low
Downgraded: risk of bias
Participant global assessment of success Not measured
Open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease vs open surgery by longitudinal incision of the skin
no estimate extractedNRNo studies
Recurrence Not measured
Open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease vs open surgery by longitudinal incision of the skin
no estimate extractedNRNo studies
Adverse events Not measured
Open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease vs open surgery by longitudinal incision of the skin
no estimate extractedNRNo studies
Neurovascular injury Not measured
Open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease vs open surgery by longitudinal incision of the skin
no estimate extractedNRNo studies

Open surgery by transverse incision of the skin in the distal palmar crease compared to open surgery by longitudinal incision of the skin for trigger finger

Population: patients with trigger finger
7 questions
OutcomeEffectEvidenceStatus / GRADE
Resolution of symptoms Not measured
Open surgery by transverse incision of the skin in the distal palmar crease vs open surgery by longitudinal incision of the skin
no estimate extractedNRNo studies
Pain (short‐term) Not measured
Open surgery by transverse incision of the skin in the distal palmar crease vs open surgery by longitudinal incision of the skin
no estimate extractedNRNo studies
Function (DASH score: 0 to 100 points)
Open surgery by transverse incision of the skin in the distal palmar crease vs open surgery by longitudinal incision of the skin
no estimate extracted1 study · 22 participantsVery low
Downgraded: risk of bias
Participant global assessment of success Not measured
Open surgery by transverse incision of the skin in the distal palmar crease vs open surgery by longitudinal incision of the skin
no estimate extractedNRNo studies
Recurrence Not measured
Open surgery by transverse incision of the skin in the distal palmar crease vs open surgery by longitudinal incision of the skin
no estimate extractedNRNo studies
Adverse events Not measured
Open surgery by transverse incision of the skin in the distal palmar crease vs open surgery by longitudinal incision of the skin
no estimate extractedNRNo studies
Neurovascular injury Not measured
Open surgery by transverse incision of the skin in the distal palmar crease vs open surgery by longitudinal incision of the skin
no estimate extractedNRNo studies

Open surgery by transverse incision of the skin in the distal palmar crease compared to open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease for trigger finger

Population: patients with trigger finger
7 questions
OutcomeEffectEvidenceStatus / GRADE
Resolution of symptoms Not measured
Open surgery by transverse incision of the skin in the distal palmar crease vs open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease
no estimate extractedNRNo studies
Pain (short‐term) Not measured
Open surgery by transverse incision of the skin in the distal palmar crease vs open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease
no estimate extractedNRNo studies
Function (DASH score: 0 to 100 points)
Open surgery by transverse incision of the skin in the distal palmar crease vs open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease
no estimate extracted1 study · 21 participantsVery low
Downgraded: risk of bias
Participant global assessment of success Not measured
Open surgery by transverse incision of the skin in the distal palmar crease vs open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease
no estimate extractedNRNo studies
Recurrence Not measured
Open surgery by transverse incision of the skin in the distal palmar crease vs open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease
no estimate extractedNRNo studies
Adverse events Not measured
Open surgery by transverse incision of the skin in the distal palmar crease vs open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease
no estimate extractedNRNo studies
Neurovascular injury Not measured
Open surgery by transverse incision of the skin in the distal palmar crease vs open surgery by transverse incision of the skin about 2–3 mm distally from distal palmar crease
no estimate extractedNRNo studies